Cargando…
An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective
BACKGROUND: Three recent randomized controlled trials have demonstrated that, as an initial rhythm control strategy, first-line cryoballoon ablation (cryoablation) reduces atrial arrhythmia recurrence compared with antiarrhythmic drugs (AADs) in patients with symptomatic paroxysmal atrial fibrillati...
Autores principales: | Wazni, Oussama, Moss, Joe, Kuniss, Malte, Andrade, Jason, Chierchia, Gian Battista, Mealing, Stuart, Mburu, Waruiru, Sale, Alicia, Kaplon, Rachelle, Ismyrloglou, Eleni, Bromilow, Tom, Lane, Emily, Lewis, Damian, Reynolds, Matthew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513914/ https://www.ncbi.nlm.nih.gov/pubmed/37744940 http://dx.doi.org/10.1016/j.hroo.2023.07.007 |
Ejemplares similares
-
An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English NHS perspective
por: Andrade, J, et al.
Publicado: (2023) -
Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation
por: Kuniss, Malte, et al.
Publicado: (2021) -
Cryoballoon Ablation for Paroxysmal Atrial Fibrillation in Septuagenarians: a Prospective Study
por: Chierchia, Gian Battista, et al.
Publicado: (2010) -
Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation
por: Hoffmann, Ellen, et al.
Publicado: (2019) -
Left atrium remodeling predicts late recurrence of paroxysmal atrial fibrillation after second generation cryoballoon ablation
por: Motoc, Andreea, et al.
Publicado: (2018)